AVE 0010 set to deliver in type 2 diabetes mellitus

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1642, 2008-01, pp. : 8-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Linagliptin: In Type 2 Diabetes Mellitus

By Scott Lesley J.

Drugs, Vol. 71, Iss. 5, 2011-03 ,pp. : 611-624

Adis International

Access to resources Recommend Favorite

The prevention of type 2 diabetes mellitus

By Davies Melanie J.

Clinical Medicine, Vol. 3, Iss. 5, 2003-09 ,pp. : 470-474

Royal College Of Physicians

Access to resources Recommend Favorite

Lixisenatide for type 2 diabetes mellitus

By Christensen Mikkel Knop Filip K Vilsbøøll Tina Holst Jens J

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 4, 2011-04 ,pp. : 549-557

Informa Healthcare

Access to resources Recommend Favorite

Vitamins and Type 2 Diabetes Mellitus

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 15, Iss. 1, 2015-03 ,pp. : 54-63

Bentham Science Publishers

Access to resources Recommend Favorite

The Pharmaceutical care of patients with type 2 diabetes mellitus

By Borges Anna

Pharmacy World and Science, Vol. 32, Iss. 6, 2010-12 ,pp. : 730-736

Springer Publishing Company

Access to resources Recommend Favorite